CVS Health (CVS) Under Analyst Spotlight Following Proposed FTC Settlement Related to Insuling Pricing

CVS Health Corporation (NYSE:CVS) is among our picks on the list titled billionaire portfolio: 7 cheap stocks top billionaires are accumulating.

CVS Health (CVS) Under Analyst Spotlight Following Proposed FTC Settlement Related to Insuling Pricing

As of March 27, 2026, the analyst consensus implies over 35% upside for CVS Health Corporation (NYSE:CVS). More than 80% of analysts maintain bullish ratings on the company despite near-term headwinds.

CVS Health Corporation (NYSE:CVS) came under analysts’ radar at Leerink after reports emerged on March 24, 2026, that the company had reached a proposed FTC settlement related to insulin pricing. While the firm’s analysts expected the outcome, they viewed it as a positive signal, as uncertainty around the PBM business would likely diminish as a result. The firm keeps its “Outperform” rating on the stock with a $98 price target.

Meanwhile, on March 19, 2026, analysts at Barclays attributed the ongoing weakness in the healthcare services segment to heightened oil prices amid the Middle East tensions. Although the sell-off surrounding the CVS stock was largely driven by geopolitical tensions, the firm believes CVS Health Corporation (NYSE:CVS) is facing concerns related to first-quarter earnings headwinds, including a lighter flu season and winter storms.

A week earlier, CVS Health Corporation (NYSE:CVS) received a vote of confidence from Bernstein as well. In addition to PBM reforms, the firm cited Aetna’s improving momentum as a key catalyst. Analysts at the firm project Aetna’s earnings to grow twofold over the next three years, driven by the normalization of Medicare Advantage margins.

CVS Health Corporation (NYSE:CVS), a diversified healthcare company, combines insurance, pharmacy benefit management, retail pharmacies, and clinical services to provide integrated healthcare solutions throughout the United States via its vertically integrated platform.

While we acknowledge the risk and potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CVS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.